Postoperative Donor Specific Anti-HLA Antibodies in Lung Transplantation: Risk Factors and Impact on Mid-Term Patient and Graft Outcomes

被引:0
|
作者
Ius, F. [1 ]
Sommer, W. [1 ]
Tudorache, I. [1 ]
Kuehn, C. [1 ]
Avsar, M. [1 ]
Siemeni, T. [1 ]
Salman, J. [1 ]
Hallensleben, M. [2 ]
Greer, M. [3 ]
Gottlieb, J. [3 ]
Haverich, A. [1 ]
Warnecke, G. [1 ]
机构
[1] Hannover Med Sch, Dept Cardiothorac Transplant & Vasc Surg, Hannover, Germany
[2] Hannover Med Sch, Dept Transfus Med, Hannover, Germany
[3] Hannover Med Sch, Dept Resp Med, Hannover, Germany
来源
关键词
D O I
10.1016/j.healun.2014.01.426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
419
引用
收藏
页码:S159 / S159
页数:1
相关论文
共 50 条
  • [41] C1Q-BINDING ANTI-HLA DONOR-SPECIFIC ANTIBODIES AND LONG-TERM KIDNEY GRAFT OUTCOMES
    Gniewkiewicz, Michal
    Czerwinska, Katarzyna
    Zielniok, Katarzyna
    Durlik, Magdalena
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I922 - I923
  • [42] COMPLEMENT-BINDING DONOR-SPECIFIC ANTI-HLA ANTIBODIES AND RISK OF PRIMARY GRAFT FAILURE IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Ciurea, S.
    Kongtim, P.
    Popat, U.
    Aung, F.
    Champlin, R.
    Cao, K.
    HAEMATOLOGICA, 2015, 100 : 278 - 278
  • [43] Impact of Low Dose Donor Specific Anti-HLA Antibodies between Living Donor versus Deceased Donor Kidney Transplantation
    Kim, S.
    Lee, S.
    Ko, E.
    Ban, T.
    Min, J.
    Yoon, H.
    Yang, C.
    Chung, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 846 - 846
  • [44] Donor specific anti-HLA antibodies are not associated with non-anastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation
    den Dulk, A. C.
    Shi, X.
    Verhoeven, C.
    Dubbeld, J.
    Claas, F. H. J.
    Wolterbeek, R.
    Brand-Schaaf, S. H.
    Verspaget, H. W.
    Sarasqueta, Farina A.
    van der Laan, L. J. W.
    Metselaar, H. J.
    van Hoek, B.
    Kwekkeboom, J.
    Roelen, D. L.
    TRANSPLANTATION, 2018, 102 : 170 - 170
  • [45] Donor-Specific HLA Antibodies: Risk Factors and Outcomes After Kidney Transplantation
    Kanter Berga, J.
    Pallardo Mateu, L. M.
    Beltran Catalan, S.
    Puig Alcaraz, N.
    Sancho Calabuig, A.
    Gavela Martinez, E.
    Avila Bemabeu, A.
    Crespo Albiach, J.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (06) : 2154 - 2156
  • [46] Anti-HLA Antibodies before and after Lung Transplantation: A Role on Medium-Long Term Outcomes?
    Benazzi, E.
    Morlacchi, L.
    Cannavo, A.
    Rosso, L.
    Palleschi, A.
    Rossetti, V.
    Righi, I.
    Passamonti, S.
    Dalpedri, B.
    Longhi, E.
    Cardillo, M.
    Tarsia, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S404 - S404
  • [47] THE IMPACT OF DONOR SPECIFIC ANTI-HLA AND ANTI-GSTT1 ANTIBODIES ON THE OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION
    Kekik, Cigdem
    Yonal, Ipek
    Oguz, Fatma Savran
    Usta, Sehabat
    Temurhan, Sonay
    Batu, Duygu
    Besisik, Sevgi Kalayoglu
    Sargin, Deniz
    TISSUE ANTIGENS, 2014, 84 (01): : 56 - 57
  • [48] The sponge effect of allograft removal on the detection of donor specific anti-HLA antibodies in lung re-transplantation
    Girnita, A. L.
    Duquesnoy, R. J.
    Lomago, J.
    Jelinek, L.
    Martell, J.
    Yousem, S. A.
    Pilewski, J.
    McCurry, K. R.
    Zeevi, A.
    HUMAN IMMUNOLOGY, 2006, 67 (10) : S85 - S85
  • [49] Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation
    Clerkin, Kevin J.
    Farr, Maryjane A.
    Restaino, Susan W.
    Zorn, Emmanuel
    Latif, Farhana
    Vasilescu, Elena R.
    Marboe, Charles C.
    Colombo, Paolo C.
    Mancini, Donna M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (05): : 540 - 545
  • [50] Relevance of donor-specific anti-HLA antibodies following renal transplantation.
    Supon, P
    Constantino, D
    Hao, P
    Cagle, LR
    Hahn, A
    Conti, DJ
    Freed, BM
    TRANSPLANTATION, 2000, 69 (08) : S185 - S185